Dr. Norbert Gleicher of the Center for Human Reproduction in New York City explains the three clinical trials on PRP (platelet-rich plasma) use for fertility purposes. The newest PRP trial, PRP3, is designed to test the hypothesis that injecting PRP into the ovaries of women with diminished ovarian reserve (DOR) might help them produce more eggs in IVF cycles. In the other two PRP clinical trials, CHR is investigating whether PRP injections into the ovaries can "reawaken" the dormant follicles in women who cannot produce eggs at all in IVF cycles. Women whose ovaries do produce eggs but not enough of them are eligible to participate in the PRP3 trial. More information about this trial is available here: http://bit.ly/365F7MD